A recording of the 2023 Preliminary Results presentation and slide deck will be available on the Group's website at www.hikma.com from
About
Contact:
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
(C) 2024 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,925 GBX | +0.05% | +5.99% | +7.77% |
Apr. 26 | HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets | |
Apr. 25 | Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024 | CI |
A recording of the 2023 Preliminary Results presentation and slide deck will be available on the Group's website at www.hikma.com from
About
Contact:
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
(C) 2024 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+7.77% | 5.35B | |
+32.02% | 704B | |
+28.38% | 577B | |
-4.63% | 348B | |
+17.90% | 327B | |
+4.48% | 288B | |
+14.74% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.63% | 147B |